Internal Medicine Expert Opines on Severe Allergic Reaction to Sulfa Drug

ByJoseph O'Neill

Updated on

Internal Medicine Expert Opines on Severe Allergic Reaction to Sulfa Drug

Case Overview

This case involves a severe reaction to a sulfa-based antibiotic which was prescribed for a urinary tract infection. The patient was a middle-aged male who had a well-documented allergy to sulfa drugs. He developed a urinary tract infection and was prescribed a sulfa based antibiotic by the Defendant physician. He took the medication that day, and shortly after, discovered that it was a sulfa drug. He immediately took 2 Benadryl pills and presented to the ER, where he was given a prescription for clindamycin. He was discharged and returned to the ER with further complaints of worsening drug reaction and blistering. He was admitted to the ICU to treat the severe drug reaction and urinary tract infection. He continues to suffer from ongoing urologic issues as well as scarring, and his quanlity of life has been seriously impacted.

Questions to the Infectious Disease and Communicable Disease expert and their responses

Q1

Do you routinely treat patients similar to the one described in the case?

I have given sulfa drugs to 1000s of patients. I have published about sulfa drugs and their side effects including severe allergic reactions including Lyell Syndrome and Stevens-Johnson Syndrome.

Q2

Have you ever had a patient develop the outcome described in the case?

I have seen several in my career and some have been quite memorable. I have seen severe sulfa allergies including fatal cases.

Q3

Is this a common complication seen with patients who are allergic to sulfa drugs?

The reaction described is not common but clearly possible. Less severe drug reactions we see all the time (average once to twice per week) but in the days of more choices in antibiotics, computerized medicine with drug allergy warnings, etc, such severe rashes have become rare.

Q4

Do you believe this patient may have had a better outcome had they have not taken this drug?

It certainly sounds like the patient would have had a better outcome had they not taken Bactrim, but it will require more data to substantiate this.

About the expert

This highly qualified double boarded expert earned his MD from the University of Hamburg. He is extensively published in his field, authoring more than 200 journal articles and 50 book chapters, and he belongs to a number of prestigious societies including the Infectious Diseases Society of America and the American Society for Microbiology. He is an invited lecturer and an invited reviewer of multiple publications and has received numerous awards for his work as a clinician and an educator. He is currently serving as a Professor of Internal Medicine, and the Chief of the Infectious Diseases Division at a top university medical center. Additionally, he is an attending physician at multiple medical centers in his region.

Expert headshot

E-010050

About the author

Joseph O'Neill

Joseph O'Neill

Joe is a seasoned expert in online journalism and technical writing, with a wealth of experience covering a diverse range of legal topics. His areas of expertise include personal injury, medical malpractice, mass torts, consumer litigation, and commercial litigation. During his nearly six years at Expert Institute, Joe honed his skills and knowledge, culminating in his role as Director of Marketing. He developed a deep understanding of the intricacies of expert witness testimony and its implications in various legal contexts. His contributions significantly enhanced the company's marketing strategies and visibility within the legal community. Joe's extensive background in legal topics makes him a valuable resource for understanding the complexities of expert witness involvement in litigation. He is a graduate of Dickinson College.

Find an expert witness near you

What State is your case in?

What party are you representing?

background image

Subscribe to our newsletter

Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.